OneSource Specialty Pharma Limited (NSE:ONESOURCE)

India · Delayed Price · Currency is INR

1,576.00

-38.80 (-2.40%)

Jun 23, 2026, 2:50 PM IST

-22.35% (1Y)

Market Cap	185.13B -14.3%
Revenue (ttm)	14.22B -1.6%
Net Income	-738.03M
EPS	-6.44
Shares Out	114.65M
PE Ratio	n/a
Forward PE	39.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	221,428
Open	1,615.10
Previous Close	1,614.80
Day's Range	1,560.10 - 1,644.00
52-Week Range	1,057.00 - 2,231.90
Beta	n/a
Analysts	Buy
Price Target	2,036.75 (+29.24%)
Earnings Date	Jul 24, 2026

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2007

Employees 1,412

Stock Exchange National Stock Exchange of India

Ticker Symbol ONESOURCE

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:ONESOURCE's revenue was 14.22 billion, a decrease of -1.61% compared to the previous year's 14.45 billion. Losses were -738.03 million, 310.7% more than in 2025.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for ONESOURCE stock is "Buy." The 12-month stock price target is ₹2,037, which is an increase of 29.24% from the latest price.

Price Target

₹2,037

(29.24% upside)

Analyst Consensus: Buy

Stock Forecasts